These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14083297)

  • 21. [Ways of increasing the effectiveness of examinations of workers in food production and food handling for typhoid-paratyphoid bacteria carrier state].
    Litinskiĭ IuI; Smirnova-Mutusheva MA; Godovannyĭ BA; Danilova LA; Golysheva AG
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):84-7. PubMed ID: 4253548
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of skim milk treated with peptin and trypsin as a culture medium for typhoid and paratyphoid B bacteria; a contribution on the use of the Wilson-Blair medium].
    POHLIG W
    Arch Hyg Bakteriol; 1950; 133(4):249-64. PubMed ID: 14800345
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vitro susceptibility of typhoid, paratyphoid and dysentery bacilli to aureomycin and chloramphenicol].
    ALIN K; WALLMARK G
    Nord Med; 1950 Apr; 43(16):663-4. PubMed ID: 14796936
    [No Abstract]   [Full Text] [Related]  

  • 24. [EFFECT OF ANTIBIOTICS ON THE SENSITIVITY OF TYPHO-PARATYPHOID PATHOGENS].
    KRYLOVA OM
    Tr Leningr Sanitarnogig Med Inst; 1963; 77():151-7. PubMed ID: 14105915
    [No Abstract]   [Full Text] [Related]  

  • 25. [The death of bacteria of the typhoid, paratyphoid-Escherichia and dysentery groups in composted refuse and in composted abattoir refuse].
    BAETGEN D
    Arch Hyg Bakteriol; 1962 Aug; 146():292-320. PubMed ID: 13966071
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acquirement of antibiotic resistance by typhoid and paratyphoid bacilli].
    YASUHARA M
    Nihon Densenbyo Gakkai Zasshi; 1962 Feb; 35():681-4. PubMed ID: 14009043
    [No Abstract]   [Full Text] [Related]  

  • 27. [Technique in determination of typhoid-paratyphoid carriers].
    BILEK M
    Med Dosw Mikrobiol; 1950; 2(3-4):402-6. PubMed ID: 14852544
    [No Abstract]   [Full Text] [Related]  

  • 28. Determination of potency of typhoid antigens by means of hemagglutination inhibition test.
    RAUSS K; KETYI I
    Pathol Microbiol (Basel); 1962; 25():235-51. PubMed ID: 14490604
    [No Abstract]   [Full Text] [Related]  

  • 29. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is the Widal reaction for typhoid and paratyphoid influenced by the oral intake of larger amounts of killed Salmonella?].
    Finger H; Seeliger H; Schmidt H
    Dtsch Med Wochenschr; 1967 May; 92(19):887-90. PubMed ID: 4960680
    [No Abstract]   [Full Text] [Related]  

  • 31. [CLINICO-IMMUNOLOGIC COMPARATIVE STUDIES ON LEVOMYCETIN THERAPY OF TYPHOID ACUTE DYSENTERY AND OF CHRONIC DYSENTERY CARRIERS AND TYPHOID CARRIERS].
    MODIAEVA NS
    Sov Med; 1964 Nov; 27():27-34. PubMed ID: 14311417
    [No Abstract]   [Full Text] [Related]  

  • 32. [THE EFFECT OF IMMUNIZATION WITH TYPHOID MONOVACCINE ON THE BACTERICIDAL PROPERTIES OF RABBIT SKIN].
    MALYSHEV FS
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Oct; 40():80-4. PubMed ID: 14134935
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of typhoid fever bacilli carrier treated by chloromycetin].
    JAKOBIEC M
    Pol Tyg Lek (Wars); 1952 Jan; 7(3-4):88-9. PubMed ID: 14929729
    [No Abstract]   [Full Text] [Related]  

  • 34. [TREATMENT OF CARRIERS OF SALMONELLA TYPHOSA AND S. PARATYPHI B BY COMBINED SURGERY AND ANTIBIOTIC THERAPY].
    KLOSE F; KNOTHE H
    Internist (Berl); 1964 Jun; 5():219-23. PubMed ID: 14234757
    [No Abstract]   [Full Text] [Related]  

  • 35. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Schwartz E
    N Engl J Med; 2009 Nov; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
    [No Abstract]   [Full Text] [Related]  

  • 36. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
    Levin DM; Wong KH; Reynolds HY; Sutton A; Northrup RS
    Infect Immun; 1975 Dec; 12(6):1290-4. PubMed ID: 54336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of paratyphoid fever vaccine research and development.
    Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
    Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental transformation of the typhoid bacillus in to paratyphoid B bacillus].
    HERRMANN W
    Z Hyg Infektionskr; 1950; 130(5):485-9. PubMed ID: 15431835
    [No Abstract]   [Full Text] [Related]  

  • 40. [The consistency of S. typhi and S. paratyphi B lysotypes in permanent disease carriers].
    Tram NT; Nass W
    Z Gesamte Hyg; 1969 Oct; 15(10):769-71. PubMed ID: 4984446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.